{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:01:48Z","timestamp":1781758908499,"version":"3.54.5"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025ZNSFSC0687"],"award-info":[{"award-number":["2025ZNSFSC0687"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473782"],"award-info":[{"award-number":["82473782"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2024ZYD0130"],"award-info":[{"award-number":["2024ZYD0130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118392","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T16:17:59Z","timestamp":1763655479000},"page":"118392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P3","title":["ALDH1A inhibitors: Research advances in cancer therapeutics"],"prefix":"10.1016","volume":"302","author":[{"given":"Xianxian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118392_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113060","article-title":"Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy","volume":"211","author":"Huddle","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118392_bib2","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.4161\/cc.10.9.15486","article-title":"Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform","volume":"10","author":"Marcato","year":"2011","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118392_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12015-010-9208-4","article-title":"The role of human aldehyde dehydrogenase in normal and cancer stem cells","volume":"7","author":"Ma","year":"2011","journal-title":"Stem cell reviews and reports"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118392_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0888-7543(88)90012-2","article-title":"Regional localization of the human genes for aldehyde dehydrogenase-1 and aldehyde dehydrogenase-2","volume":"2","author":"Raghunathan","year":"1988","journal-title":"Genomics"},{"issue":"11","key":"10.1016\/j.ejmech.2025.118392_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/FPC.0b013e3283329023","article-title":"Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature","volume":"19","author":"Black","year":"2009","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.ejmech.2025.118392_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110120","article-title":"Aldehyde dehydrogenase 1A1 and 1A3 isoforms - mechanism of activation and regulation in cancer","volume":"87","author":"Poturnajova","year":"2021","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118392_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488808786734006","article-title":"Aldehyde dehydrogenase as a marker for stem cells","volume":"3","author":"Moreb","year":"2008","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118392_bib8","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.18632\/oncotarget.6920","article-title":"Aldehyde dehydrogenase 1A1 in stem cells and cancer","volume":"7","author":"Tomita","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118392_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.17219\/dmp\/144575","article-title":"Aldehyde dehydrogenase 1: its key role in cell physiology and oral carcinogenesis","volume":"59","author":"Swain","year":"2022","journal-title":"Dental and medical problems"},{"key":"10.1016\/j.ejmech.2025.118392_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1026278","article-title":"ALDH1: a potential therapeutic target for cancer stem cells in solid tumors","volume":"12","author":"Wei","year":"2022","journal-title":"Frontiers in oncology"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/ijms26010251","article-title":"The significance of aldehyde Dehydrogenase 1 in cancers","volume":"26","author":"Nguyen","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10585-015-9755-9","article-title":"Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors","volume":"33","author":"Rodriguez-Torres","year":"2016","journal-title":"Clin. Exp. Metastasis"},{"issue":"24","key":"10.1016\/j.ejmech.2025.118392_bib13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.21037\/atm.2016.11.82","article-title":"Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets","volume":"4","author":"Clark","year":"2016","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.canlet.2015.08.018","article-title":"Aldehyde dehydrogenases and cancer stem cells","volume":"369","author":"Xu","year":"2015","journal-title":"Cancer letters"},{"key":"10.1016\/j.ejmech.2025.118392_bib15","article-title":"Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells","volume":"2019","author":"Vassalli","year":"2019","journal-title":"Stem Cell. Int."},{"issue":"22","key":"10.1016\/j.ejmech.2025.118392_bib16","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.7150\/jca.62123","article-title":"Synergistic killing effects of PD-L1-CAR T cells and colorectal cancer stem cell-dendritic cell vaccine-sensitized T cells in ALDH1-positive colorectal cancer stem cells","volume":"12","author":"Liu","year":"2021","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s13046-018-0975-0","article-title":"Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid\/HIF-1\u03b1\/VEGF signalling in MCF-7 breast cancer cells","volume":"37","author":"Ciccone","year":"2018","journal-title":"Journal of experimental & clinical cancer research : CR"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s42003-022-03311-1","article-title":"Structural and biochemical evidence that ATP inhibits the cancer biomarker human aldehyde dehydrogenase 1A3","volume":"5","author":"Castellv\u00ed","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2025.118392_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.795762","article-title":"Emerging roles of aldehyde dehydrogenase isoforms in anti-cancer therapy resistance","volume":"9","author":"Zanoni","year":"2022","journal-title":"Front. Med."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118392_bib20","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1021\/bi00008a025","article-title":"Investigation of the active site cysteine residue of rat liver mitochondrial aldehyde dehydrogenase by site-directed mutagenesis","volume":"34","author":"Farr\u00e9s","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118392_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep35710","article-title":"Crystal structure of human aldehyde dehydrogenase 1A3 complexed with NAD+ and retinoic acid","volume":"6","author":"Moretti","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1073\/pnas.1011223108","article-title":"Structural shifts of aldehyde dehydrogenase enzymes were instrumental for the early evolution of retinoid-dependent axial patterning in metazoans","volume":"108","author":"Sobreira","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejmech.2025.118392_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108256","article-title":"Structural and kinetic features of aldehyde dehydrogenase 1A (ALDH1A) subfamily members, cancer stem cell markers active in retinoic acid biosynthesis","volume":"681","author":"Pequerul","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118392_bib24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cell.2008.09.002","article-title":"Retinoic acid synthesis and signaling during early organogenesis","volume":"134","author":"Duester","year":"2008","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118392_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000000083","article-title":"Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease","volume":"82","author":"Fitzmaurice","year":"2014","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ejmech.2025.118392_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182208","article-title":"Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma","volume":"12","author":"Yang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118392_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.918778","article-title":"ALDH1A1 in cancers: bidirectional function, drug resistance, and regulatory mechanism","volume":"12","author":"Yue","year":"2022","journal-title":"Frontiers in oncology"},{"key":"10.1016\/j.ejmech.2025.118392_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151696","article-title":"The role of ALDH1A1 in contributing to breast tumour aggressiveness: a study conducted in an African population","volume":"51","author":"Gyan","year":"2021","journal-title":"Ann. Diagn. Pathol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118392_bib30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.amjsurg.2019.07.016","article-title":"Clinical and pathological stage discordance among 433,514 breast cancer patients","volume":"218","author":"Plichta","year":"2019","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.ejmech.2025.118392_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/sci.2018.03.04","article-title":"Cutaneous metastases of breast cancer during adjuvant chemotherapy correlates with increasing CD44+\/CD24- and ALDH-1 expression: a case report and literature review","volume":"5","author":"Lee","year":"2018","journal-title":"Stem Cell Invest."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118392_bib32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5114\/pjp.2020.99792","article-title":"Aldehyde dehydrogenase-1 positivity is associated with ER negativity in patients with invasive ductal carcinoma of the breast","volume":"71","author":"K\u00f6y","year":"2020","journal-title":"Pol. J. Pathol. : official journal of the Polish Society of Pathologists"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/stem.563","article-title":"Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis","volume":"29","author":"Marcato","year":"2011","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"6","key":"10.1016\/j.ejmech.2025.118392_bib34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s12282-018-0875-3","article-title":"Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer","volume":"25","author":"Louhichi","year":"2018","journal-title":"Breast cancer (Tokyo, Japan)"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118392_bib35","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1159\/000493227","article-title":"ALDH1 expression and vasculogenic mimicry are positively associated with poor prognosis in patients with breast cancer","volume":"49","author":"Xing","year":"2018","journal-title":"Cell. Physiol. Biochem. : international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118392_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10549-018-4793-z","article-title":"Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness","volume":"170","author":"Shima","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118392_bib37","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.7150\/thno.41647","article-title":"An evolving paradigm of cancer stem cell hierarchies: therapeutic implications","volume":"10","author":"Cole","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118392_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/cbin.11939","article-title":"Recent advances in cold atmospheric plasma (CAP) for breast cancer therapy","volume":"47","author":"Chupradit","year":"2023","journal-title":"Cell Biol. Int."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118392_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","article-title":"Current cancer epidemiology","volume":"9","author":"Mattiuzzi","year":"2019","journal-title":"Journal of epidemiology and global health"},{"issue":"8","key":"10.1016\/j.ejmech.2025.118392_bib40","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/diagnostics11081463","article-title":"ALDH1 and SALL4 expression in cell block samples from patients with lung adenocarcinoma and malignant pleural effusion","volume":"11","author":"Kanayama","year":"2021","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118392_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101025","article-title":"Exploitation of the vitamin A\/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin","volume":"14","author":"MacDonagh","year":"2021","journal-title":"Transl. Oncol."},{"issue":"15","key":"10.1016\/j.ejmech.2025.118392_bib42","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-13-3292","article-title":"Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway","volume":"20","author":"Shao","year":"2014","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118392_bib43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/1574888X13666180810120012","article-title":"ALDH as a stem cell marker in solid tumors","volume":"14","author":"Toledo-Guzm\u00e1n","year":"2019","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118392_bib44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/1574888X13666180810120012","article-title":"ALDH as a stem cell marker in solid tumors","volume":"14","author":"Toledo-Guzm\u00e1n","year":"2019","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib45","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1039\/D3MD00543G","article-title":"Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation","volume":"15","author":"Narendra","year":"2023","journal-title":"RSC Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118392_bib46","first-page":"1686","article-title":"Everolimus combined with 5-aza-2-deoxycytidine generated potent anti-tumor effects on ovarian clear cell cancer stem-like\/spheroid cells by inhibiting the COL6A3-AKT-mTOR pathway","volume":"12","author":"Ho","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1158\/1535-7163.MCT-19-0242","article-title":"ALDH1A1 contributes to PARP inhibitor resistance via enhancing DNA repair in BRCA2-\/- ovarian cancer cells","volume":"19","author":"Liu","year":"2020","journal-title":"Mol. Cancer Therapeut."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118392_bib48","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.celrep.2019.02.032","article-title":"A Pan-ALDH1A inhibitor induces necroptosis in ovarian cancer stem-like cells","volume":"26","author":"Chefetz","year":"2019","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118392_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.111938","article-title":"Identification of very small cancer stem cells expressing hallmarks of pluripotency in B16F10 melanoma cells and their reoccurrence in B16F10-derived clones","volume":"391","author":"Dias C\u00e2mara","year":"2020","journal-title":"Experimental cell research"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/biomedicines10010007","article-title":"ALDH1A3 segregated expression and nucleus-associated proteasomal degradation are common traits of glioblastoma stem cells","volume":"10","author":"Fau\u00df","year":"2021","journal-title":"Biomedicines"},{"issue":"24","key":"10.1016\/j.ejmech.2025.118392_bib51","doi-asserted-by":"crossref","first-page":"9568","DOI":"10.3390\/ijms21249568","article-title":"Androgen deprivation induces transcriptional reprogramming in prostate cancer cells to develop stem cell-like characteristics","volume":"21","author":"Verma","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.ejmech.2025.118392_bib52","doi-asserted-by":"crossref","first-page":"9462","DOI":"10.1002\/cam4.3538","article-title":"Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk","volume":"9","author":"Cao","year":"2020","journal-title":"Cancer Med."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118392_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206685","article-title":"The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer","volume":"13","author":"Huang","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118392_bib54","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ijc.32505","article-title":"ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression","volume":"146","author":"Namekawa","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.ejmech.2025.118392_bib55","first-page":"3656","article-title":"The expressions of CD133, ALDH1, and vasculogenic mimicry in osteosarcoma and their clinical significance","volume":"11","author":"Bao","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118392_bib56","first-page":"1827","article-title":"The mitochondrial one-carbon metabolic pathway is associated with patient survival in pancreatic cancer","volume":"16","author":"Noguchi","year":"2018","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118392_bib57","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/path.5341","article-title":"The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis","volume":"249","author":"Hsu","year":"2019","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118392_bib58","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1158\/1541-7786.MCR-21-1039","article-title":"Loss of PBRM1 alters promoter histone modifications and activates ALDH1A1 to drive renal cell carcinoma","volume":"20","author":"Schoenfeld","year":"2022","journal-title":"Mol. Cancer Res. : MCR"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib59","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1186\/s12885-018-4572-6","article-title":"ALDH1A inhibition sensitizes colon cancer cells to chemotherapy","volume":"18","author":"Kozovska","year":"2018","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.ejmech.2025.118392_bib60","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/stem.1193","article-title":"ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets","volume":"30","author":"Luo","year":"2012","journal-title":"Stem cells (Dayton, Ohio)"},{"key":"10.1016\/j.ejmech.2025.118392_bib61","article-title":"Transcriptional expressions of ALDH1A1\/B1 as independent indicators for the survival of thyroid cancer patients","volume":"12","author":"Cui","year":"2022","journal-title":"Frontiers in oncology"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118392_bib62","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1021\/jm501900s","article-title":"Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors","volume":"58","author":"Morgan","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118392_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112940","article-title":"Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors","volume":"209","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118392_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116352","article-title":"Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity","volume":"46","author":"Ma","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118392_bib65","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1021\/acs.jmedchem.8b00270","article-title":"Discovery of orally bioavailable, quinoline-based aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with potent cellular activity","volume":"61","author":"Yang","year":"2018","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118392_bib66","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1021\/acs.jmedchem.6b01825","article-title":"Inhibition of the aldehyde dehydrogenase 1\/2 family by Psoralen and coumarin derivatives","volume":"60","author":"Buchman","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118392_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111923","article-title":"Discovery of coumarin-based selective aldehyde dehydrogenase 1A1 inhibitors with glucose metabolism improving activity","volume":"187","author":"Liang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"43","key":"10.1016\/j.ejmech.2025.118392_bib68","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/s41388-024-03156-4","article-title":"ALDH1A3 is the switch that determines the balance of ALDH+ and CD24-CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer","volume":"43","author":"Fernando","year":"2024","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118392_bib69","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/pr.111.005538","article-title":"Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application","volume":"64","author":"Koppaka","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib70","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cbi.2011.10.007","article-title":"The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance","volume":"195","author":"Moreb","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.118392_bib71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cbi.2014.12.008","article-title":"N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes","volume":"234","author":"Morgan","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"15","key":"10.1016\/j.ejmech.2025.118392_bib72","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1021\/acs.jmedchem.5b00577","article-title":"Discovery of NCT-501, a potent and selective theophylline-based inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1)","volume":"58","author":"Yang","year":"2015","journal-title":"J. Med. Chem."},{"issue":"1\u20133","key":"10.1016\/j.ejmech.2025.118392_bib73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0009-2797(00)00225-8","article-title":"In vivo inhibition of aldehyde dehydrogenase by disulfiram","volume":"130\u2013132","author":"Lipsky","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.118392_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127958","article-title":"Development of new disulfiram analogues as ALDH1a1-selective inhibitors","volume":"40","author":"Omran","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"18","key":"10.1016\/j.ejmech.2025.118392_bib75","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/onc.2014.178","article-title":"\u03b2-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids","volume":"34","author":"Condello","year":"2015","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118392_bib76","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/cancers11040502","article-title":"A novel ALDH1A1 inhibitor targets cells with stem cell characteristics in ovarian cancer","volume":"11","author":"Nwani","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.118392_bib77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cbi.2014.10.028","article-title":"Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1","volume":"234","author":"Morgan","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"14","key":"10.1016\/j.ejmech.2025.118392_bib78","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.3390\/cancers14143437","article-title":"A novel ALDH1A1 inhibitor blocks platinum-induced senescence and stemness in ovarian cancer","volume":"14","author":"Muralikrishnan","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.ejmech.2025.118392_bib79","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/andr.13807","article-title":"Kinetics of the inhibition and recovery of spermatogenesis induced by treatment with WIN 18,446, a male contraceptive, in mice","volume":"13","author":"Paik","year":"2025","journal-title":"Andrology"},{"issue":"21","key":"10.1016\/j.ejmech.2025.118392_bib80","doi-asserted-by":"crossref","first-page":"15104","DOI":"10.1074\/jbc.M113.540211","article-title":"Inhibition of retinoic acid biosynthesis by the bisdichloroacetyldiamine WIN 18,446 markedly suppresses spermatogenesis and alters retinoid metabolism in mice","volume":"289","author":"Paik","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118392_bib81","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1194\/jlr.M054718","article-title":"Importance of ALDH1A enzymes in determining human testicular retinoic acid concentrations","volume":"56","author":"Arnold","year":"2015","journal-title":"Journal of lipid research"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118392_bib82","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1021\/acschembio.7b00685","article-title":"Structural basis of ALDH1A2 inhibition by irreversible and reversible small molecule inhibitors","volume":"13","author":"Chen","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib83","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/s42003-021-02949-7","article-title":"A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells","volume":"4","author":"Li","year":"2021","journal-title":"Commun. Biol."},{"issue":"Web Server issue","key":"10.1016\/j.ejmech.2025.118392_bib84","doi-asserted-by":"crossref","first-page":"W409","DOI":"10.1093\/nar\/gks378","article-title":"ZINCPharmer: pharmacophore search of the ZINC database","volume":"40","author":"Koes","year":"2012","journal-title":"Nucleic acids research"},{"key":"10.1016\/j.ejmech.2025.118392_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6561047","article-title":"ALDH1A3-Linc00284 axis mediates the invasion of colorectal cancer by targeting TGF\u03b2 signaling via sponging miR-361-5p","volume":"2022","author":"Ke","year":"2022","journal-title":"International journal of genomics"},{"key":"10.1016\/j.ejmech.2025.118392_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215662","article-title":"An aldehyde dehydrogenase 1A3 inhibitor attenuates the metastasis of human colorectal cancer","volume":"536","author":"Duan","year":"2022","journal-title":"Cancer letters"},{"issue":"19","key":"10.1016\/j.ejmech.2025.118392_bib87","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.3390\/molecules26195770","article-title":"Design, synthesis, biological evaluation and in silico study of benzyloxybenzaldehyde derivatives as selective ALDH1A3 inhibitors","volume":"26","author":"Ibrahim","year":"2021","journal-title":"Molecules"},{"issue":"59","key":"10.1016\/j.ejmech.2025.118392_bib88","doi-asserted-by":"crossref","first-page":"99382","DOI":"10.18632\/oncotarget.19544","article-title":"Inhibition of aldehyde dehydrogenase 1 enhances the cytotoxic effect of retinaldehyde on A549 cancer cells","volume":"8","author":"Park","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118392_bib89","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cyto.b.20161","article-title":"Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay","volume":"72","author":"Moreb","year":"2007","journal-title":"Cytometry B Clin. Cytometry"},{"issue":"7467","key":"10.1016\/j.ejmech.2025.118392_bib90","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature12624","article-title":"Tumour heterogeneity and cancer cell plasticity","volume":"501","author":"Meacham","year":"2013","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ejmech.2025.118392_bib91","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrd4253","article-title":"Tackling the cancer stem cells - what challenges do they pose?","volume":"13","author":"Pattabiraman","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"20","key":"10.1016\/j.ejmech.2025.118392_bib92","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1021\/jm0101390","article-title":"Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway","volume":"44","author":"Gao","year":"2001","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2025.118392_bib93","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1158\/0008-5472.CAN-15-2860","article-title":"FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells","volume":"76","author":"Cheng","year":"2016","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118392_bib94","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1021\/acs.jmedchem.9b01910","article-title":"Imidazo[1,2-a]pyridine derivatives as aldehyde dehydrogenase inhibitors: novel chemotypes to target glioblastoma stem cells","volume":"63","author":"Quattrini","year":"2020","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118392_bib95","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/acsmedchemlett.9b00686","article-title":"Progress in the field of aldehyde dehydrogenase inhibitors: novel Imidazo[1,2-a]pyridines against the 1A family","volume":"11","author":"Quattrini","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118392_bib96","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/cancers13020356","article-title":"A selective competitive inhibitor of Aldehyde dehydrogenase 1A3 hinders cancer cell growth, invasiveness and stemness in vitro","volume":"13","author":"Gelardi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.118392_bib97","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/1471-2407-12-329","article-title":"Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures","volume":"12","author":"Saw","year":"2012","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.ejmech.2025.118392_bib98","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"19","key":"10.1016\/j.ejmech.2025.118392_bib99","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1021\/acs.jmedchem.8b00930","article-title":"Structure-based optimization of a novel class of aldehyde dehydrogenase 1A (ALDH1A) subfamily-selective inhibitors as potential adjuncts to ovarian cancer chemotherapy","volume":"61","author":"Huddle","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118392_bib100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cbi.2019.04.004","article-title":"Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: kinetic characterization and effect on human cancer cells","volume":"306","author":"Jim\u00e9nez","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118392_bib101","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/1535-7163.MCT-19-0360","article-title":"Development of a novel multi-isoform ALDH inhibitor effective as an Antimelanoma agent","volume":"19","author":"Dinavahi","year":"2020","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2025.118392_bib102","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ygyno.2023.07.015","article-title":"A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors","volume":"176","author":"McGonigal","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"21","key":"10.1016\/j.ejmech.2025.118392_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111512","article-title":"Targeting retinaldehyde dehydrogenases to enhance temozolomide therapy in glioblastoma","volume":"25","author":"Jim\u00e9nez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118392_bib104","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3390\/cimb45030139","article-title":"In vitro evaluation of ALDH1A3-Affinic compounds on breast and prostate cancer cell lines as single treatments and in combination with Doxorubicin","volume":"45","author":"Abusara","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118392_bib105","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1021\/acsptsci.5c00395","article-title":"Integrated approach of machine learning and high-throughput screening to identify chemical probe candidates targeting Aldehyde dehydrogenases","volume":"8","author":"Yasgar","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118392_bib106","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tips.2024.06.006","article-title":"BTK inhibitors: past, present, and future","volume":"45","author":"Cool","year":"2024","journal-title":"Trends in pharmacological sciences"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118392_bib107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","article-title":"Artificial intelligence in drug development","volume":"31","author":"Zhang","year":"2025","journal-title":"Nature medicine"},{"issue":"11","key":"10.1016\/j.ejmech.2025.118392_bib108","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.7150\/ijbs.83026","article-title":"Emerging pharmacotherapeutic strategies to overcome undruggable proteins in cancer","volume":"19","author":"Lu","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118392_bib109","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1080\/07391102.2023.2300127","article-title":"Identification of approved drugs with ALDH1A1 inhibitory potential aimed at enhancing chemotherapy sensitivity in cancer cells: an in-silico drug repurposing approach","volume":"43","author":"Paul","year":"2025","journal-title":"Journal of biomolecular structure & dynamics"},{"issue":"5","key":"10.1016\/j.ejmech.2025.118392_bib110","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1158\/2159-8290.CD-20-1243","article-title":"CRISPR screening of CAR T cells and cancer stem cells reveals critical dependencies for cell-based therapies","volume":"11","author":"Wang","year":"2021","journal-title":"Cancer Discov."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:08:42Z","timestamp":1777529322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":109,"alternative-id":["S0223523425011572"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118392","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALDH1A inhibitors: Research advances in cancer therapeutics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118392"}}